[e-med] L'OMS a publié la 15ème liste modèle de médicaments essentiels

["Carinne Bruneton" <c.bruneton@remed.org>]

Chers e-médiens et e-médiennes

La nouvelle liste des médicamnts essentiels est maintenant disponible sur le site de du départemant médicaments de l'OMS à cette adresse 

http://www.who.int/entity/medicines/publications/EML15.pdf 

Comme le rappelle Wilbert sur e-drug, c'est la 15ème liste en 30 ans et le processus de révision de la liste est maintenant mature et transparent

On peut trouver ci-dessous une note pour les médias WHO/17
13 April 2007
EXPERTS RECOMMEND INNOVATION FOR CHILDREN'S MEDICINES
WHO 15TH ESSENTIAL MEDICINES LIST PUBLISHED TODAY
http://www.who.int/medicines/news/EML15_WHO_NoteForMedia17_2007en.pdf

Carinne Bruneton
Modératrice de e-med
Email: c.bruneton@remed.org

Les archives de e-med sont disponibles à  http://www.essentialdrugs.org/emed/

----- Message d'origine ----- 
De : "Wilbert Bannenberg" <wjb@wxs.nl>
À : <e-drug@healthnet.org>
Envoyé : lundi 16 avril 2007 00:35
Objet : [e-drug] WHO publishes 15th edition Model EML


> E-DRUG: WHO publishes 15th edition Model EML
> ------------------------------------------------------
> 
> Dear E-druggers,
> 
> E-drug understands that following clearance by the office of the Director
> General, and final editing, the 15th list of Essential medicines has now
> been made available on the Medicines web site at:
> 
> http://www.who.int/entity/medicines/publications/EML15.pdf 
> 
> This is the 15th edition in 30 years. WHO has not yet made public whether it
> wants to "celebrate" the 30th birthday of the EML. Clearly the list is now a
> mature adult with a transparent process.
> 
> Below is a "note for the media" from WHO. Copied as fair use from:
> http://www.who.int/medicines/news/EML15_WHO_NoteForMedia17_2007en.pdf
> 
> Regards
> 
> Wilbert 
> 
> 
> ---------
> Wilbert Bannenberg, E-drug moderator
> Email: wjb@planet.nl
> 
> The E-drug archives are available at http://www.essentialdrugs.org/edrug/
> 
> (un)Subscribe E-drug at:
> http://list.healthnet.org/mailman/listinfo/e-drug
> 
> ---
> 
> Note for the media WHO/17
> 13 April 2007
> 
> EXPERTS RECOMMEND INNOVATION FOR CHILDREN'S MEDICINES 
> 
> WHO 15TH ESSENTIAL MEDICINES LIST PUBLISHED TODAY
> 
> Following recommendations from the Expert Committee on Essential Medicines,
> the World Health Organization (WHO) will immediately begin work to create a
> medicines list specifically tailored to children's needs. A group of experts
> will meet in July 2007 to produce the first international list of medicines
> to tackle diseases with high mortality and morbidity rates in children.
> 
> The Expert Committee made the recommendation while meeting on 19-23 March in
> Geneva to update the general WHO Model List of Essential Medicines. The list
> will be published today and already includes some child specific medicines.
> 
> Children suffer from the same illnesses as adults but they are more
> seriously affected - particularly in developing countries - by certain
> conditions such as respiratory tract infections, malaria and diarrhoeal
> diseases. An estimated 10.6 million children under five die every year, many
> from these treatable conditions. In 2005, 2.3 million children under 15
> years were HIV positive - 700 000 new infections had occurred over the
> twelve months.
> 
> In spite of the huge need, there are few medicines made to measure for
> children or that can be easily consumed by a child. At present, children
> must often take portions of adult tablets in a crushed form, with little
> evidence of the efficacy and safety of the dose. When medicines do exist in
> the right dosage they are usually in syrup form, which may pose supply,
> storage and pricing problems in developing countries.
> 
> The challenge for children becomes more acute when they are affected by a
> condition requiring combination therapy (several medicines rather than one)
> such as for HIV/AIDS and malaria. In these cases, fixed dose combination
> tablets are required (two- or three-in-one pills). While production of adult
> fixed-dose-combinations is increasing, it is sorely lacking for children. In
> addition, antiretrovirals for children are currently three times more
> expensive than the adult versions.
> 
> The recommendation made by the Expert Committee for an essential medicines
> list for children will see WHO working with partners to advocate innovation
> and research into children's medicines, the manufacture of new dosage forms
> and new formats, and ways in
> which information about children's medicines can be conveyed to countries in
> a rapid, effective way.
> 
> The plan to work on better medicines for children was strongly backed by
> Member States at WHO's Executive Board meeting in January this year and will
> be on the agenda of the World Health Assembly in May.
> 
> The Expert Committee made a number of important updates to the WHO Model
> List of Essential Medicines. Five fixed-dose-combinations for adults were
> included for HIV/AIDS. Two of these come from the generic industry while the
> remaining three are produced by brand name companies. All WHO recommended
> antimalarials were also added.
> 
> Five oral liquid formulations were included for children - three for
> epilepsy, one for children born prematurely, and one new medicine for
> HIV/AIDS, although in single dose. Three other epilepsy medicines were
> included in the form of chewable, dispersable tablets, a format which
> evidence increasingly shows to be effective for children.
> 
> The WHO List of Essential Medicines provides a model for countries to select
> medicines addressing public health priorities according to quality, safety
> and efficacy standards. It helps governments address problems of cost and
> availability and provides guidance to the pharmaceutical industry on
> medicines needs globally.
> 
> For more information contact:
> 
> Daniela Bagozzi, Communications officer, WHO, Geneva, Tel: +41 (22) 791
> 4544; mobile: +41 79 475 5490; Email: bagozzid@who.int.
> All WHO News Releases, Fact Sheets and Features can be obtained on the WHO
> web site: www.who.int.
> 
> _______________________________________________
> Post message: e-drug@healthnet.org
> Subscribe: e-drug-join@healthnet.org
> Unsubscribe: e-drug-leave@healthnet.org
> Help: e-drug-owner@healthnet.org
> Info & archives: http://list.healthnet.org/mailman/listinfo/e-drug
>